Anti-hyperuricemia effect of ethanol and n-hexane fractions of celery leaf and stem in Wistar rats
Abstract
This study investigated the antihyperuricemic effects of ethanol and n-hexane fractions derived from celery (Apium graveolens L.) leaves and stems in potassium oxonate-induced Wistar rats. Celery plant materials were subjected to extraction and subsequent fractionation using ethanol and n-hexane. Phytochemical profiling using gas chromatography–mass spectrometry (GC–MS) identified the presence of phenolic compounds across all fractions. Serum uric acid levels were measured before and after induction, followed by treatment with allopurinol and the respective celery fractions. Statistical analysis revealed significant differences in uric acid levels among treatment groups after intervention. In vitro xanthine oxidase (XO) inhibition was assessed using UV–Vis spectrophotometry, with allopurinol demonstrating the highest inhibitory activity, followed by the ethanol fraction of celery stems. Histopathological evaluation of renal tissues showed glomerular necrosis in the untreated hyperuricemic group, while varying degrees of renal damage persisted in groups treated with celery fractions, particularly at higher doses of leaf extracts. Overall, the findings suggest that ethanol and n-hexane fractions of celery possess antihyperuricemic potential, likely mediated through XO inhibition, although their renal protective effects appear limited under the conditions tested.
There is no Figure or data content available for this article
References
- 1. Skoczyńska M, Chowaniec M, Szymczak A, Langner-Hetmańczuk A, Maciążek-Chyra B, Wiland P. Pathophysiology of hyperuricemia and its clinical significance – a narrative review. Reumatologia. 2020;58(5):312–23. doi:10.5114/reum.2020.100140
- 2. Petreski T, Ekart R, Hojs R, Bevc S. Hyperuricemia, the heart, and the kidneys–to treat or not to treat? Ren Fail. 2020;42(1):978–86. doi:10.1080/0886022X.2020.1822185 PubMed PMID: 32972284.
- 3. Golmohammadi S, Tavasoli M, Asadi N. Prevalence and risk factors of hyperuricemia in patients with chronic kidney disease and non-alcoholic fatty liver. Clin Exp Gastroenterol. 2020;13:299–304. doi:10.2147/CEG.S253619
- 4. Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci. 2021;22(17). doi:10.3390/ijms22179221 PubMed PMID: 34502127.
- 5. Sowbhagya HB. Chemistry, Technology, and Nutraceutical Functions of Celery (Apium graveolens L.): An Overview. Crit Rev Food Sci Nutr. 2014;54(3):389–98. doi:10.1080/10408398.2011.586740 PubMed PMID: 24188309.
- 6. Usman, Prasetya I, Putra GJ, Wuriani. Pengaruh Pemberian Air Rebusan Seledri (Apium Graveolens L.) Terhadap Kadar Asam Urat pada Penderita Gout Artritis di Rasau Jaya. Health Sciences and Pharmacy Journa. 2018;2(1):1–7. doi:10.1016/S1084-8592(99)80001-0
- 7. Amis RT, Novalinda Ginting C, Ferdinand S, Ikhtiari R. Anti-hyperuricemia of Avocado Leaves Ethanol Extract in Potassium Oxonate Induced-Rats. In: InHeNce 2021 - 2021 IEEE International Conference on Health, Instrumentation and Measurement, and Natural Sciences. 2021. doi:10.1109/InHeNce52833.2021.9537287
- 8. Hedayati N, Bemani Naeini M, Mohammadinejad A, Mohajeri SA. Beneficial effects of celery (Apium graveolens) on metabolic syndrome: A review of the existing evidences. Phytotherapy Research. 2019;33(12):3040–53. doi:10.1002/ptr.6492 PubMed PMID: 31464016.
- 9. Li S, Li L, Yan H, Jiang X, Hu W, Han N, et al. Anti-gouty arthritis and anti-hyperuricemia properties of celery seed extracts in rodent models. Mol Med Rep. 2019;20(5):4623–33. doi:10.3892/mmr.2019.10708 PubMed PMID: 31702020.
- 10. Al-Din A, Pill Baek J, Mady E, Eldekashy M, Craker L. Phytochemical Analysis of Some Celery Accessions. Journal of Medicinally Active Plants. 2015;4(1):1–7.
- 11. Yao Y, Sang W, Zhou M, Ren G. Phenolic composition and antioxidant activities of 11 celery cultivars. J Food Sci. 2010;75(1):9–13. doi:10.1111/j.1750-3841.2009.01392.x PubMed PMID: 20492156.
- 12. Tashakori-Sabzevar F, Razavi BM, Imenshahidi M, Daneshmandi M, Fatehi H, Sarkarizi YE, et al. Evaluation of mechanism for antihypertensive and vasorelaxant effects of hexanic and hydroalcoholic extracts of celery seed in normotensive and hypertensive rats. Revista Brasileira de Farmacognosia. 2016;26(5):619–26. doi:10.1016/j.bjp.2016.05.012
- 13. Tashakori-Sabzevar F, Ramezani M, Hosseinzadeh H, Parizadeh SMR, Movassaghi AR, Ghorbani A, et al. Protective and hypoglycemic effects of celery seed on streptozotocin-induced diabetic rats: experimental and histopathological evaluation. Acta Diabetol. 2016;53(4):609–19. doi:10.1007/s00592-016-0842-4 PubMed PMID: 26940333.
- 14. Dianat M, Veisi A, Ahangarpour A, Fathi Moghaddam H. The effect of hydro-alcoholic celery (Apiumgraveolens) leaf extract on cardiovascular parameters and lipid profile in animal model of hypertension induced by fructose. Avicenna J Phytomed. 2015;5(3):203–9. PubMed PMID: 26101753.
- 15. Guo J, Wu Z, Yun X, Amist N, Li L. Allelopathic effects of acetone extract from celery rotten roots and rhizosphere soil on cucumber pathogen fusarium oxysporum f. Sp. cucumerinum. Allelopathy Journal. 2021;52(2). doi:10.26651/allelo.j/2021-52-2-1316
- 16. Iswantini D, Nadinah, Darusman LK, Trivadila. Inhibition kinetic of apium graveolens l. ethanol extract and its fraction on the activity of xanthine oxidase and its active compound. Journal of Biological Sciences. 2012. p. 51–6. doi:10.3923/jbs.2012.51.56
- 17. Kooti W, Daraei N. A Review of the Antioxidant Activity of Celery (Apium graveolens L). J Evid Based Complementary Altern Med. 2017;22(4):1029–34. doi:10.1177/2156587217717415
- 18. Lyu W, Qin H, Zhou X, Zhang Y, Lu D, Shao Y, et al. Xanthine oxidase inhibitors for gout: Applications and novel drug development. Eur J Med Chem. 2026;307:118619. doi:https://doi.org/10.1016/j.ejmech.2026.118619
- 19. Qian H, Wang M, Xu H, Feng K, Li Y, Hu Y, et al. Ultrasound-assisted aqueous two-phase extraction of flavonoids from erigeron breviscapus: process optimization, structural characterization, antioxidant study, and DFT calculation. Sci Rep. 2026;16(1):11831. doi:10.1038/s41598-026-41556-6
- 20. Jian Y, Zhong X, Wang J, Wang F, Yu S, Guo J, et al. Nutraceutical potential of a novel phytonutrients formula in managing hyperuricemia: In silico, in vitro, and in vivo investigations. J Funct Foods. 2025;129:106849.
- 21. Bai H, Zhang Z, Zhu M, Sun Y, Wang Y, Li B, et al. Research progress of treating hyperuricemia in rats and mice with traditional Chinese medicine. Front Pharmacol. 2024;15:1428558.
- 22. Li K, Wang Y, Liu W, Zhang C, Xi Y, Zhou Y, et al. Structure–activity relationships and changes in the inhibition of xanthine oxidase by polyphenols: A review. Foods. 2024;13(15):2365.
- 23. Keefe P, Puthanveetil P. Compare and contrast of the cellular actions of related flavonoids, apigenin and chrysin. Nutrients. 2024;16(23):4195.
- 24. Zummah A, Martha RD. Antihyperurisemic Activity of Aqueous Celery Infusion by Xanthine Oxidase Enzyme Inhibition. Majalah Obat Tradisional. 2018;23(3):131. doi:10.22146/mot.38500
- 25. Indraningsih. Penetapan Kadar Flavonoid Total Dan Aktivitas Antioksidan Dari Ekstrak Dan Fraksi Daun Seledri (Apium Graveolens L.) Dengan Metode Abts. 2020.
- 26. Dolati K, Rakhshandeh H, Golestani M, Forouzanfar F, Sadeghnia R, Sadeghnia HR. Inhibitory effects of apium graveolens on xanthine oxidase activity and serum Uric acid levels in hyperuricemic mice. Prev Nutr Food Sci. 2018;23(2):127–33. doi:10.3746/pnf.2018.23.2.127
- 27. Kartikasari D. Uji Toksisitas Akut Ekstrak Batang Seledri (Apium Graveolens) Dengan Metode BSLT (Brine Shrimp Lethality Test). Proceeding of the pharmacy 2022. 2022;1(2):1–23.
- 28. Din ZU, Shad AA, Bakht J, Ullah I, Jan S. In vitro antimicrobial, antioxidant activity and phytochemical screening of Apium graveolens. Pak J Pharm Sci. 2015;28(5):1699–704. PubMed PMID: 26408890.
- 29. Mardiana ZA, Ardiaria M, Ayustaningwarno F, Rahadiyanti A. Pengaruh Pemberian Sari Edamame (Glycine Max (L.) Merrill) terhadap Kadar Asam Urat Tikus Wistar Jantan Diabetes. Journal of Nutrition College. 2022;11(1):51–61. doi:10.14710/jnc.v11i1.31603
- 30. Masuoka N, Kubo I. Characterization of the xanthine oxidase inhibitory activity of alk(en)yl phenols and related compounds. Phytochemistry. 2018;155(February):100–6. doi:10.1016/j.phytochem.2018.07.006 PubMed PMID: 30096514.
- 31. Chamarelza S. Fakultas Kedokteran Universitas Andalas 1. jurnal Fakultas Kedokteran Universitas Andalas 1. 2019.
- 32. Yasheshwar, Gaurav, Ekkbal R, Gupta P, Gyawali R. System Pharmacological Approach to Investigate and Validate Multitargeted and Therapeutic Effect of Furocoumarins of Apium graveolens L. for Treatment of Kidney Disease. Adv Pharmacol Pharm Sci. 2024 Jan 1;2024(1):5543561. doi:https://doi.org/10.1155/2024/5543561
How to Cite This
Copyright and Permissions

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Publishing your paper with Jurnal Teknologi Laboratorium (JTL) means that the author or authors retain the copyright in the paper. JTL granted an exclusive reuse license by the author(s), but the author(s) are able to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by JTL in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.
JTL journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially.
JTL journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:
- BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
